Literature DB >> 21542021

Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression.

Michael S Remple1, Courtney H Bradenham, C Chris Kao, P David Charles, Joseph S Neimat, Peter E Konrad.   

Abstract

Parkinson's disease is a neurodegenerative disorder characterized by progressive loss of dopaminergic cells in the central nervous system, in particular the substantia nigra, resulting in an unrelenting loss of motor and nonmotor function. Animal models of Parkinson's disease reveal hyperactive neurons in the subthalamic nucleus that have increased firing rates and bursting activity compared with controls. Although subthalamic nucleus activity has been characterized in patients with advanced-stage Parkinson's disease, it has not been described in patients with early-stage Parkinson's disease. Here we present the results of subthalamic nucleus neuronal recordings from patients with early-stage Parkinson's disease (Hoehn and Yahr stage II) enrolled in an ongoing clinical trial compared with recordings from age- and sex-matched patients with advanced Parkinson's disease. Subthalamic nucleus neurons had a significantly lower firing rate in early versus advanced Parkinson's disease (28.7 vs 36.3 Hz; P<.01). The overall activity of the subthalamic nucleus was also significantly lower in early versus late Parkinson's disease, as measured by background neuronal noise (12.4 vs 14.0 mV; P<.05). No significant difference was identified between groups in the bursting or variability of neuronal firing in the subthalamic nucleus, as measured by a burst index or the interspike interval coefficient of variability. The results suggest that neuronal firing in the subthalamic nucleus increases with Parkinson's disease progression.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21542021      PMCID: PMC3151310          DOI: 10.1002/mds.23708

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  39 in total

1.  Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting.

Authors:  M Zonenshayn; A R Rezai; A Y Mogilner; A Beric; D Sterio; P J Kelly
Journal:  Neurosurgery       Date:  2000-08       Impact factor: 4.654

2.  Parkinsonism: onset, progression, and mortality. 1967.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  2001-11       Impact factor: 9.910

3.  The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics.

Authors:  M C Rodriguez-Oroz; M Rodriguez; J Guridi; K Mewes; V Chockkman; J Vitek; M R DeLong; J A Obeso
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

4.  Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease.

Authors:  Abdelhamid Benazzouz; Sorin Breit; Adnan Koudsie; Pierre Pollak; Paul Krack; Alim-Louis Benabid
Journal:  Mov Disord       Date:  2002       Impact factor: 10.338

5.  Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats.

Authors:  Z G Ni; R Bouali-Benazzouz; D M Gao; A L Benabid; A Benazzouz
Journal:  Brain Res       Date:  2001-04-27       Impact factor: 3.252

6.  Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.

Authors:  Douglas E Hobson; Anthony E Lang; W R Wayne Martin; Ajmal Razmy; Jean Rivest; Jonathan Fleming
Journal:  JAMA       Date:  2002 Jan 23-30       Impact factor: 56.272

7.  Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients.

Authors:  M Magnin; A Morel; D Jeanmonod
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Subthalamic neuron activity related to tremor and movement in Parkinson's disease.

Authors:  C M Magariños-Ascone; R Figueiras-Mendez; C Riva-Meana; A Córdoba-Fernández
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

Review 9.  From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control.

Authors:  Thomas Boraud; Erwan Bezard; Bernard Bioulac; Christian E Gross
Journal:  Prog Neurobiol       Date:  2002-03       Impact factor: 11.685

10.  Transdermal rotigotine for the perioperative management of Parkinson's disease.

Authors:  Ullrich Wüllner; Jan Kassubek; Per Odin; Michael Schwarz; Markus Naumann; Hermann-Josef Häck; Babak Boroojerdi; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

View more
  22 in total

1.  Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.

Authors:  David Charles; Peter E Konrad; Joseph S Neimat; Anna L Molinari; Michael G Tramontana; Stuart G Finder; Chandler E Gill; Mark J Bliton; Chris Kao; Fenna T Phibbs; Peter Hedera; Ronald M Salomon; Kevin R Cannard; Lily Wang; Yanna Song; Thomas L Davis
Journal:  Parkinsonism Relat Disord       Date:  2014-03-28       Impact factor: 4.891

2.  Functional MRI Signature of Chronic Pain Relief From Deep Brain Stimulation in Parkinson Disease Patients.

Authors:  Marisa DiMarzio; Tanweer Rashid; Ileana Hancu; Eric Fiveland; Julia Prusik; Michael Gillogly; Radhika Madhavan; Suresh Joel; Jennifer Durphy; Eric Molho; Era Hanspal; Damian Shin; Julie G Pilitsis
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

3.  Effect of levodopa on electroencephalographic biomarkers of the parkinsonian state.

Authors:  Andrew M Miller; Svjetlana Miocinovic; Nicole C Swann; Sheila S Rajagopalan; David M Darevsky; Ro'ee Gilron; Coralie de Hemptinne; Jill L Ostrem; Philip A Starr
Journal:  J Neurophysiol       Date:  2019-05-08       Impact factor: 2.714

Review 4.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

5.  Abnormal Bursting as a Pathophysiological Mechanism in Parkinson's Disease.

Authors:  Cj Lobb
Journal:  Basal Ganglia       Date:  2014-04-01

6.  Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo.

Authors:  Qihui Wu; Muhammad A Shaikh; Emily S Meymand; Bin Zhang; Kelvin C Luk; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2020-10-06       Impact factor: 17.088

7.  Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale.

Authors:  David Charles; Christopher Tolleson; Thomas L Davis; Chandler E Gill; Anna L Molinari; Mark J Bliton; Michael G Tramontana; Ronald M Salomon; Chris Kao; Lily Wang; Peter Hedera; Fenna T Phibbs; Joseph S Neimat; Peter E Konrad
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

Review 8.  Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis.

Authors:  Fabin Lin; Dihang Wu; Chenxin Lin; Huihui Cai; Lina Chen; Guofa Cai; Qinyong Ye; Guoen Cai
Journal:  Neurochem Res       Date:  2020-01-16       Impact factor: 3.996

9.  Movement-related coupling of human subthalamic nucleus spikes to cortical gamma.

Authors:  Petra Fischer; Witold J Lipski; Wolf-Julian Neumann; Robert S Turner; Pascal Fries; Peter Brown; R Mark Richardson
Journal:  Elife       Date:  2020-03-11       Impact factor: 8.140

Review 10.  Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson's Disease: Current Understanding and Knowledge Gaps.

Authors:  Taylor E Huntington; Rahul Srinivasan
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.